Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1.
Cheung, M., Kuntz, K.W., Pobanz, M., Salovich, J.M., Wilson, B.J., Andrews, C.W., Shewchuk, L.M., Epperly, A.H., Hassler, D.F., Leesnitzer, M.A., Smith, J.L., Smith, G.K., Lansing, T.J., Mook, R.A.(2008) Bioorg Med Chem Lett 18: 6214-6217
- PubMed: 18929484 Search on PubMed
- DOI: https://doi.org/10.1016/j.bmcl.2008.09.100
- Primary Citation Related Structures: 
3EOC - PubMed Abstract: 
The synthesis and biological activities of imidazo[5,1-f][1,2,4]triazin-2-amines (imidazotriazines) as novel polo-like kinase 1 inhibitors are reported.
- GlaxoSmithKline, Fire Moore Drive, Research Triangle Park, NC 27709, USA. mui.h.cheung@gsk.com
Organizational Affiliation: 

















